Abstract:The metastatic spread of breast carcinoma to the stomach is rare. There are a small number of previous studies that report metastases from the breast to the stomach and these provide limited information regarding this infrequent event. Consequently, the clinicopathological features, clinical outcomes and the optimal treatment for these patients remain to be elucidated. In the present study, 78 cases of gastric metastases from breast cancer, including the current case, were identified from previous studies between 1960 and 2015. The clinicopathological features of primary breast tumors and metastatic gastric lesions, including initial stage, tumor size, hormone receptor status, treatment modalities and overall survival (OS) rate, were analyzed. The patients were all female and the median age at the time of gastric metastasis diagnosis was 59 years old (range, 38-86 years). The majority of the patients initially presented with stage II breast cancer (35.9%) and abdominal pain was the most common symptom of gastric metastases (75.6%). A total of 51/78 patients (65.4%) were identified to have a history of invasive lobular breast carcinoma and the majority of gastric tumors were positive for hormonal receptors and human epidermal growth factor receptor 2 (HER-2) negative (estrogen receptor, 94.0%; progesterone receptor, 68.3%; HER-2, 5.9%). Furthermore, in the univariate analysis, multiple organs involved prior to or at the time of gastric metastases were diagnosed and multiple gastric lesions and peritoneal carcinomatosis were significantly correlated with OS. Additionally, salvage hormonal therapy, but not surgery or chemotherapy, significantly extended OS. However, in the multivariate analysis, metastasis prior to stomach involvement was the only independent indicator of poor OS. In conclusion, physicians must be vigilant when patients with breast cancer history present with gastrointestinal symptoms, despite gastric metastasis from breast cancer being rare. An appropriate systemic therapeutic strategy that includes hormonal therapy may be beneficial for this group of patients.

Gastrointestinal metastases from primary lung cancer

Gastrointestinal Hemorrhage Due to Ileal Metastasis from Primary Lung Cancer

Gastrointestinal Metastasis of Primary Lung Cancer: an Analysis of 366Ï¿½cases

Gastric and duodenal squamous cell carcinoma: metastatic or primary?

Total obstruction of small intestine due to metastatic lung adenocarcinoma

Case Series Analysis of Diagnosis and Treatment of Gastrointestinal Metastasis in Lung Cancer Patients

Metastatic Gastric Cancer from Breast Carcinoma: A Report of 78 Cases

Prevalence, Clinicopathological Characteristics, Treatment, and Prognosis of Intestinal Metastasis of Primary Lung Cancer: A Comprehensive Review

[Primary Lung Cancer with Gastrointestinal Metastasis: 2 Case Report and Literature Review].

A Case of Small Intestinal Hemorrhage Secondary to Metastatic Lung Cancer in the Elderly.

Metachronous Primary Adenocarcinoma of Lung During Adjuvant Imatinib Mesylate Therapy for Gastrointestinal Stromal Tumor of Stomach A Case Report

Gastrointestinal bleeding due to pancreatic metastasis of non-small cell lung cancer: A report of two cases and a literature review

Metastatic spread of primary lung adenocarcinoma to the small intestine: A case report

Acute Small Bowel Obstruction: a Rare Initial Presentation for the Metastasis of the Large-Cell Carcinoma of the Lung.

Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center

Lung carcinoma with small intestinal metastases and gastrointestinal bleeding: A rare case report

Clinical Characteristics and Prognosis of Gastrointestinal Metastases in Solid Tumor Patients: A Retrospective Study and Review of Literatures

Colonic Metastasis after Resection of Primary Squamous Cell Carcinoma of the Lung: A Case Report and Literature Review

Lung adenocarcinoma patient progression with gastrointestinal metastasis response to subsequent tyrosine kinase inhibitors (TKIs) from re-biopsy of new occurring driver gene mutation.

Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases

Gastric and small bowel metastases from lung adenocarcinoma: A case report